Recently diagnosed with HIV? Click here

Newly diagnosed

Dealing with a positive diagnosis and coming to terms with the challenge of living with HIV is never easy. But today the prospects for successful treatment and increased life expectancy are better than ever before, and there are a wide range of support services available to help people living with HIV in Australia.

If you've recently been told you‘re HIV positive, you may be feeling scared, confused or anxious. The resources and articles below may help to answer some of your questions and allay some of your concerns.

If you need support to help you come to terms with your diagnosis, state and territory PLWHA groups and AIDS Councils covering every part of Australia can help by putting you in touch with peer support groups, counsellors, medical services and health information.

Key resources

Cover image - Next Steps 2008

An AFAOAustralian Federation of AIDS Organisations. AFAO is the peak non-government organisation representing Australia's community-based response to HIV/AIDS. AFAO's work includes education, policy, advocacy and international projects. /NAPWA education resource for people recently-diagnosed with HIV infection. Information about getting support, treatments, disclosure and more.

HIV+ Gay Sex (cover)

A booklet about being gay, having HIV and sex. Second Edition (2002).

Getting the best HIV care (cover image)

NAPWA has produced this guide to help HIV-positive Australians make the best decisions they can about their health, care and treatment.

Treataware to host two 'Chin Wags' during Mardi Gras

Story • Graham Stocks • 28 January 2010

As part of Mardi Gras Festival celebrations this year, NAPWA's Treataware is putting on two CHIN WAG chat shows, one in the east of town, at the Cambridge Hotel in Surry Hills, and one in the west, at the Clarence, in Petersham. Positive people, their friends, partners, carers and other interested parties are all welcome. read more »

HIV Seroconversion Study 2007 - 9

Report • Scott Lockhart • 19 October 2009

The Seroconversion StudyA clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. trialA clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase IA clinical trial designed to establish whether an experimental drug is safe for humans to take. Phase I studies determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and look for early evidence of effectiveness; these studies may include either people with HIV, HIV-negative volunteers, or both tests a new drug or treatment in a small group; Phase IIA smaller clinical trial designed to establish whether a drug is effective. Phase II studies are conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. If there is evidence that the drug is effective, a Phase III study is undertaken, with a larger number of participaants, to confirm this. expands the study to a larger group of people; Phase IIIA large clinical trial designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. expands the study to an even larger group of people; and Phase IVPost-marketing studies to delineate additional information including the drug's risks, benefits, and optimal use. takes place after the drug or treatment has been licensed and marketed. collects both quantitative and qualitative data from mainly homosexual men who have recently been diagnosed with HIV. Men are referred to the online questionaire through clinics and HIV organisations providing services to men who are newly diagnosed. Men completing the online questionaire volunteer for the more extended depth interview. read more »

HIV Seroconversion Study

Story • Jill Sergeant • 6 August 2009

The HIV Seroconversion StudyA clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. trialA clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase IA clinical trial designed to establish whether an experimental drug is safe for humans to take. Phase I studies determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and look for early evidence of effectiveness; these studies may include either people with HIV, HIV-negative volunteers, or both tests a new drug or treatment in a small group; Phase IIA smaller clinical trial designed to establish whether a drug is effective. Phase II studies are conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. If there is evidence that the drug is effective, a Phase III study is undertaken, with a larger number of participaants, to confirm this. expands the study to a larger group of people; Phase IIIA large clinical trial designed to establish whether a drug is effective and safe enough for widespread use. Phase III studies include expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling. expands the study to an even larger group of people; and Phase IVPost-marketing studies to delineate additional information including the drug's risks, benefits, and optimal use. takes place after the drug or treatment has been licensed and marketed. is a study of men who have been recently infected with HIV. It will provide valuable information for health promotion efforts and may be used in the development of health promotion materials for gay and other men who have sex with men. read more »

Getting the best HIV care

Resource • 7 May 2009

NAPWA has produced this guide to help HIV-positive Australians make the best decisions they can about their health, care and treatment. read more »

Just diagnosed?

From Treat Yourself Right • 5 January 2009

From the resource Treat Yourself Right, information for positive women who have recently been diagnosed. read more »

Next steps

Resource • 1 December 2008

An AFAOAustralian Federation of AIDS Organisations. AFAO is the peak non-government organisation representing Australia's community-based response to HIV/AIDS. AFAO's work includes education, policy, advocacy and international projects. /NAPWA education resource for people recently-diagnosed with HIV infection. Information about getting support, treatments, disclosure and more. read more »

Positively identified

Positive Living article • David Menadue • 10 July 2006

Is being HIV-positive an innate part of our identities as positive people, or has the concept of “HIV identity” become less significant in the post-HAARTHighly Active AntiRetroviralA medication or other substance which is active against retroviruses such as HIV. Therapy ??? aggressive treatment of HIV infection using several different drugs together. era? DAVID MENADUE investigates. read more »

Non-nukes

Positive Living article • Paul Kidd • 10 July 2006

Non-nucleosides are a powerful option for treating HIV, but cross-resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.. can mean you only get one bite of the cherry. This is the final instalment in a three-part series looking at key drug classesA group of anti-HIV drugs with the same target of action. Anti-HIV drug classes include nucleoside analogue reverse transcriptase inhibitors, protease inhibitorsA type of anti-HIV drug that works by preventing the production of an enzyme, protease, that HIV needs to replicate. and non-nucleoside analogue reverse transcriptase inhibitors, as well as several others. Combining drugs from three or more classes is the basis of Highly Active AntiretroviralA medication or other substance which is active against retroviruses such as HIV. Therapy (HAARTHighly Active AntiRetroviral Therapy ??? aggressive treatment of HIV infection using several different drugs together.).read more »

Adherence tips

Positive Living article • Paul Kidd • 8 December 2005

Thirty-two quick and easy strategies to help you take your medications on time. read more »

Sticking to it

Positive Living article • Paul Kidd • 8 December 2005

Why is adherence – taking your antiretroviralA medication or other substance which is active against retroviruses such as HIV. medications on time and not missing doses – such a big deal? read more »

Syndicate content
Text size: font smallerfont normalfont larger

In this section

Stay in touch

NAPWA's email newsletters provide regular info about issues affecting people with HIV and the response to HIV in Australia. Click here to subscribe.

Subscribe to Positive Living

Our free quarterly newsmagazine, Positive Living provides authoritative, independent information about living with HIV and HIV treatments. Click here to subscribe.

RSS feeds

Our website has RSS feeds covering all topic areas — just go to the topic area you're interested in and click the RSS feed icon.

Twitter users can stay up-to-date with NAPWA's work and be alerted to new content on the website by following @napwa.

HIV Clinical Trials update